K. Peter Hirth is listed as a director on 5 SEC Form D filings by 1 issuer between Sep 2009 and Mar 2014: KOLLTAN PHARMACEUTICALS INC (New Haven, CT — biotechnology — 2009–2014; $60M reported sold to 54 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
The issuer belongs to the sponsor group Overbrook (8 issuers, $662.5M reported sold, 2009–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Overbrook has 8 companies on file and $662.5M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for K. Peter Hirth and found 9 differences, 3 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.